Skip to content

Divya Vats, MD

NPI 1154515963ActiveIndividual· Medical Genetics, Clinical Biochemical Genetics· Los Angeles, CA

Medical Genetics, Clinical Biochemical Genetics (MD) with Southern California Permanente Medical Group, practicing in Los Angeles, California. Part D covered 203 prescriptions written in 2024, 39% of them generic. Otsuka Pharmaceutical Development & Commercialization, Inc. reported $1,300 in payments in 2024, mostly consulting fees.

Overview

NPI1154515963
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedSep 5, 2007
Last updated in NPPESDec 8, 2021

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Family Practice (CA); Practitioner - Medical Genetics and Genomics (HI)

Part D prescriptions in 2024

Prescriptions (claims)203 · 227 30-day fills
Patients31
Total drug cost$3,140,673
Generic share39% of claims

Medicare sources and data years

Education and affiliations

Graduation year1998
Medicare specialtyFamily Practice
Secondary specialtiesMedical Genetics And Genomics

Medical group

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2024$1,300 · 2 payments from 1 company

Top paying companies in 2024

What the 2024 payments were for

  • Consulting Fee$1,300 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Medical Genetics, Clinical Biochemical Genetics providers in Los Angeles

All Medical Genetics, Clinical Biochemical Genetics providers in California